Immuron (IMRN) Non-Current Assets (2016 - 2025)
Immuron (IMRN) recorded quarterly Non-Current Assets of $1146.2 in Q3 2025, down 98.44% quarter-over-quarter from $73403.9 in Q2 2025, and down 86.08% on a YoY basis from $8236.3 in Q3 2024.
Immuron (IMRN) Non-Current Assets (2016 - 2025) Analysis & Trends
Immuron's Non-Current Assets history runs 10 years deep, the most recent figure standing at $1146.2 for Q3 2025.
- In Q3 2025, Non-Current Assets fell 86.08% year-over-year to $1146.2; the TTM figure through Sep 2025 stood at $1146.2 (down 86.08% YoY), while the FY2025 annual figure was $1146.2, down 86.08% from the prior year.
- Non-Current Assets was $1146.2 for Q3 2025 at Immuron, down from $73403.9 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.1 million in Q2 2023 to a low of $1146.2 in Q3 2025.
- Historically, Non-Current Assets has averaged $529319.4 across 5 years, with a median of $660246.0 in 2022.
- The sharpest annual moves came in 2021 and 2023: Non-Current Assets surged 5253.33% in 2021, then tumbled 99.22% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $951863.6 in 2021, then declined by 18.3% to $777698.3 in 2022, then sank by 99.22% to $6093.8 in 2023, then soared by 4347.25% to $271005.5 in 2024, then sank by 99.58% to $1146.2 in 2025.
- The last three Non-Current Assets figures came in at $1146.2 (Q3 2025), $73403.9 (Q2 2025), and $271005.5 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 62,953.78 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 30.30 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 39.71 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 1,146.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 1,146.16 |
| Jun 30, 2025 | 73,403.89 |
| Dec 31, 2024 | 271,005.50 |
| Sep 9, 2024 | 8,236.32 |
| Jun 30, 2024 | 542,793.65 |
| Dec 31, 2023 | 6,093.77 |
| Sep 28, 2023 | 1.03 Mn |
| Aug 30, 2023 | 15,788.45 |
| Jun 30, 2023 | 1.06 Mn |
| Dec 31, 2022 | 777,698.31 |
| Aug 31, 2022 | 823,152.59 |
| Jun 30, 2022 | 847,826.76 |
| Dec 31, 2021 | 951,863.60 |
| Jun 30, 2021 | 1.00 Mn |
| Dec 31, 2020 | 17,780.76 |
| Sep 1, 2020 | 1.79 Mn |
| Jun 30, 2020 | 1.18 Mn |
| Dec 31, 2019 | 17,931.22 |
| Jun 30, 2019 | 1.32 Mn |
| Dec 31, 2018 | 2.19 Mn |